Macromolecules as targeted drugs delivery vehicles: an overview

References

• Prasad D, Chauhan H. Key targeting approaches for pharmaceutical drug delivery. Am Pharm Rev. 2013;16(6).
   Google Scholar
• Wang B, Hu L, Siahaan TJ. Drug delivery: principles and applications. Hoboken: John Wiley & Sons; 2016.
   Google Scholar
• Yousaf A, Hamid SA, Bunnori NM, et al. Applications of calixarenes in cancer chemotherapy: facts and perspectives. Drug Des Devel Ther. 2015;9:2831.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24(3):179–191.
   PubMed Web of Science ®Google Scholar
• Hoffman AS. The origins and evolution of “controlled” drug delivery systems. J Control Release. 2008;132(3):153–163.
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991–1003.
   PubMed Web of Science ®Google Scholar
• Jain KK. Drug delivery systems-an overview. Drug delivery systems. Humana Press; 2008. p. 1–50.
   Google Scholar
• Daraee H, Etemadi A, Kouhi M, et al. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44(1):381–391.
   PubMed Web of Science ®Google Scholar
• Li T, Takeoka S. Smart liposomes for drug delivery. Smart nanoparticles for biomedicine. 2018:31–47.
   Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Tagami T, Ozeki T. Recent trends in clinical trials related to carrier-based drugs. J Pharm Sci. 2017:2219–2226.
   PubMed Web of Science ®Google Scholar
• Khodabandehloo H, Zahednasab H, Hafez AA. Nanocarriers usage for drug delivery in cancer therapy. Iran J Cancer Prev. 2016;9(2).
   PubMedGoogle Scholar
• Rathbone M. Advances in delivery science and technology. Boston, MA: Springer; 2012.
   Google Scholar
• Okamoto Y, Taguchi K, Yamasaki K, et al. Albumin-encapsulated liposomes: a novel drug delivery carrier with hydrophobic drugs encapsulated in the inner aqueous core. J Pharm Sci. 2018;107(1):436–445.
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M. Factors affecting drug release from liposomes. Curr Opin Drug Discov Devel. 2010;13(1):111–123.
   PubMedGoogle Scholar
• Zhang X, Zong W, Bi H, et al. Hierarchical drug release of pH-sensitive liposomes encapsulating aqueous two phase system. Eur J Pharm Biopharm. 2018;127:177–182.
   PubMed Web of Science ®Google Scholar
• Kulthe SS, Choudhari YM, Inamdar NN, et al. Polymeric micelles: authoritative aspects for drug delivery. Des Monomers Polym. 2012;15(5):465–521.
   Web of Science ®Google Scholar
• Xu W, Ling P, Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv. 2013;2013.
   Google Scholar
• Senapati S, Mahanta AK, Kumar S, et al. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):7.
   PubMed Web of Science ®Google Scholar
• Luque-Michel E, Imbuluzqueta E, Sebastián V, et al. Clinical advances of nanocarrier-based cancer therapy and diagnostics. Expert Opin Drug Deliv. 2017;14(1):75–92.
   PubMed Web of Science ®Google Scholar
• Mochida Y, Cabral H, Kataoka K. Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opin Drug Deliv. 2017;14:1423–1438. (just-accepted).
   PubMed Web of Science ®Google Scholar
• Movassaghian S, Merkel OM, Torchilin VP. Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(5):691–707.
   PubMed Web of Science ®Google Scholar
• Varela-Moreira A, Shi Y, Fens MH, et al. Clinical application of polymeric micelles for the treatment of cancer. Mater Chem Front. 2017;1:1485–1501.
   Web of Science ®Google Scholar
• Caminade A-M, Turrin C-O. Dendrimers for drug delivery. J Mat Chem B. 2014;2(26):4055–4066.
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Grinstaff MW. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev. 2008;60(9):1037–1055.
   PubMed Web of Science ®Google Scholar
• Tomalia DA, Cheng Y. Dendrimer-based drug delivery systems: from theory to practice. Hoboken: John Wiley & Sons; 2012.
   Google Scholar
• Sharma AK, Gothwal A, Kesharwani P, et al. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. Drug Discov Today. 2017;22(2):314–326.
   PubMed Web of Science ®Google Scholar
• Wang H, Huang Q, Chang H, et al. Stimuli-responsive dendrimers in drug delivery. Biomater Sci. 2016;4(3):375–390.
   PubMed Web of Science ®Google Scholar
• Gutsche CD. Calixarenes: an introduction: royal society of chemistry. Tucson.2008.
   Google Scholar
• Hamilton K. Synthesis, characterization, and application of water-soluble chiral calix [4] arene derivatives in spectroscopy and capillary electrokinetic chromatography. Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Chemistry by Kim Hamilton BS, Baton Rouge, Louisiana, Southern University; 2003.
   Google Scholar
• Galindo-Murillo R, Sandoval-Salinas ME, Barroso-Flores J. In silico design of monomolecular drug carriers for the tyrosine kinase inhibitor drug imatinib based on calix-and thiacalix [n] arene host molecules: a DFT and molecular dynamics study. J Chem Theory Comput. 2014;10(2):825–834.
   PubMed Web of Science ®Google Scholar
• Iijima S. Carbon nanotubes: past, present, and future. Phys B Condens Matter. 2002;323(1):1–5.
   Web of Science ®Google Scholar
• Kar KK. Carbon nanotubes: synthesis, characterization and applications. India: Research Publishing Service; 2011.
   Google Scholar
• Chandrasekhar P. CNT applications in drug and biomolecule delivery. Conducting polymers, fundamentals and applications. Cham: Springer; 2018. p. 61–64.
   Google Scholar
• Zhang W, Zhang Z, Zhang Y. The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett. 2011;6(1):555.
   PubMed Web of Science ®Google Scholar
• Karimi M, Solati N, Ghasemi A, et al. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin Drug Deliv. 2015;12(7):1089–1105.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev. 2013;65(9):1215–1233.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1):1–11.
   PubMed Web of Science ®Google Scholar
• Conceicao J, Adeoye O, Cabral-Marques HM, et al. Cyclodextrins as drug carriers in pharmaceutical technology: the state of the art. Curr Pharm Des. 2018;24(13):1405–1433.
   PubMed Web of Science ®Google Scholar
• Gidwani B, Vyas A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015;2015.
   PubMed Web of Science ®Google Scholar
• Duchêne D, Cavalli R, Gref R. Cyclodextrin-based polymeric nanoparticles as efficient carriers for anticancer drugs. Curr Pharm Biotechnol. 2016;17(3):248–255.
   PubMed Web of Science ®Google Scholar
• Rudek MA, Chau CH, Figg WD, et al. Handbook of anticancer pharmacokinetics and pharmacodynamics. New York: Springer; 2014.
   Google Scholar
• Liechty WB, Peppas NA. Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm. 2012;80(2):241–246.
   PubMed Web of Science ®Google Scholar
• Larson N, Ghandehari H. Polymeric conjugates for drug delivery. Chem Mater. 2012;24(5):840.
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, Schubert US, Knop K, Hoogenboom R, Fischer D, et al. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem. 2010;49(36):6288–6308.
   Google Scholar
• Kolate A, Baradia D, Patil S, et al. PEG—a versatile conjugating ligand for drugs and drug delivery systems. J Control Release. 2014;192:67–81.
   PubMed Web of Science ®Google Scholar
• D’souza AA, Shegokar R. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opin Drug Deliv. 2016;13(9):1257–1275.
   PubMed Web of Science ®Google Scholar
• Jiwpanich S. Design and synthesis of a new class of self-cross-linked polymer nanogels. Amherst: University of Massachusetts Amherst. 2011.
   Google Scholar
• Chourasia M, Jain S. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci. 2003;6(1):33–66.
   PubMed Web of Science ®Google Scholar
• Tong X, Wang G, Soldera A, et al. How can azobenzene block copolymer vesicles be dissociated and reformed by light? J Phys Chem A. 2005;109(43):20281–20287.
   Web of Science ®Google Scholar
• Saint-Cricq P, Deshayes S, Zink J, et al. Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core–shell mesoporous silica nanoparticles. Nanoscale. 2015;7(31):13168–13172.
   PubMed Web of Science ®Google Scholar